# US 2004/0082049 A1 · Method of screening compounds that inhibit lysophosphatidic acid acyltransferase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082049 A1
- Document ID: US20040082049A1
- Status: Published application
- Kind: A1
- Application number: 10/667,462
- Filed: 2003-09-23
- Published: 2004-04-29
- Earliest claimed: 1996-03-19
- Assignees: Cell Therapeutics, Inc.
- Inventors: David W. Leung; Daniel Adourel; David Hollenback
- Web page: https://patentgrep.com/patent/US20040082049A1

## CPC

- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.

## Claims

### Claim 1

An isolated polypeptide having LPAAT activity, comprising the amino acid sequence SEQ ID NO: 15 and enzymatically active fragments thereof.
